Patents by Inventor Nicholas A. Shaw

Nicholas A. Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10384874
    Abstract: A control device is described for rollers of a trailer. Belt supports and belt-end supports attach to the trailer, which has rollers for unloading cargo. The belt is over each of the belt supports and under each of the rollers. A belt tensioner tensions the belt so as to brake the rollers.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: August 20, 2019
    Assignee: Anderson Industries LLC
    Inventors: Nicholas Shaw, Daniel Geiger, Daniel Ewert, Joel Jorgenson
  • Publication number: 20130225524
    Abstract: The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula I: wherein R1, R2, R3, R4, and R5 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    Type: Application
    Filed: November 3, 2011
    Publication date: August 29, 2013
    Inventors: Deping Chai, Mariela Colon, Christopher Dodson, Kevin J. Duffy, Antony Nicholas Shaw
  • Publication number: 20110098324
    Abstract: The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
    Type: Application
    Filed: June 23, 2009
    Publication date: April 28, 2011
    Inventors: James A. Brackley, III, Antony Nicholas Shaw, Rosanna Tedesco, Yonghui Wang, Kenneth J. Wiggall, Hongyi Yu
  • Patent number: 7553652
    Abstract: The present invention relates to a novel process for the preparation of (S)— or (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid and to novel microorganisms capable of utilizing the propionamide of the formula in the form of the racemate or of its optically active isomers as the sole nitrogen source.
    Type: Grant
    Filed: August 10, 2005
    Date of Patent: June 30, 2009
    Assignee: Lonza AG
    Inventors: Walter Brieden, Andrew Naughton, Karen Robins, Nicholas Shaw, Andreas Tinschert, Thomas Zimmermann
  • Publication number: 20070196900
    Abstract: The present invention relates to the manufacture of antibiotic compounds of the class known as lantibiotics. Preferably, the present invention relates to the purification of those lantibiotics.
    Type: Application
    Filed: February 13, 2007
    Publication date: August 23, 2007
    Inventors: Hubert Muellner, Martin Folger, Andreas Werner, Uwe Gierlich, Kurt Eyer, Klaus Heinzmann, Nicholas Shaw, Fabian Wyer
  • Publication number: 20060177919
    Abstract: The present invention relates to a novel process for the preparation of (S)— or (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid and to novel microorganisms capable of utilizing the propionamide of the formula in the form of the racemate or of its optically active isomers as the sole nitrogen source.
    Type: Application
    Filed: August 10, 2005
    Publication date: August 10, 2006
    Applicant: LONZA AG.
    Inventors: Walter Brieden, Andrew Naughton, Karen Robins, Nicholas Shaw, Andreas Tinschert, Thomas Zimmermann
  • Patent number: 7074606
    Abstract: The present invention relates to a novel process for the preparation of (S)- or (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid and to novel microorganisms capable of utilizing the propionamide of the formula in the form of the racemate or of its optically active isomers as the sole nitrogen source.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: July 11, 2006
    Assignee: Lonza AG
    Inventors: Walter Brieden, Andrew Naughton, Karen Robins, Nicholas Shaw, Andreas Tinschert, Thomas Zimmermann
  • Patent number: 6773910
    Abstract: Described are new micro-organisms and a new enzyme capable of using as sole source of nitrogen the propionic acid amide of formula (VI), in racemate form or as optically active isomers. Described also is a method of preparing (S)- or (R)-3,3,2-trifluoro-2-hydroxy-2-methylpropionic acid of formulas (I) and (II) starting from trifluoroaceto-acetic ester. The first three process steps are chemical, the fourth process step microbiological.
    Type: Grant
    Filed: December 30, 1999
    Date of Patent: August 10, 2004
    Inventors: Walter Brieden, Andrew Naughton, Karen Robins, Nicholas Shaw, Andreas Tinschert, Thomas Zimmermann
  • Patent number: 6599721
    Abstract: The invention relates to a novel method for the preparation of optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives of the general formulae (I) and (II), in which R is ethyl or methyl and X is OH or NH2, provided that if R is methyl X≠—OH. The method comprises the reaction of a racemic propionic acid amide of the general formula (III) either by means of microorganisms which are able to use the propionic acid amide in the form of the racemate or one of its optically active isomers as the only nitrogen source or by means of a polypeptide with amidohydrolase activity which is able to hydrolyze the propionic acid amide. The invention also relates to new optically active representatives of this category of compounds.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: July 29, 2003
    Assignee: Lonza AG
    Inventors: Andrew Naughton, Nicholas Shaw
  • Publication number: 20030087402
    Abstract: The present invention relates to a novel process for the preparation of (S)- or (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid and to novel microorganisms capable of utilizing the propionamide of the formula 1
    Type: Application
    Filed: February 28, 2002
    Publication date: May 8, 2003
    Inventors: Walter Brieden, Andrew Naughton, Karen Robins, Nicholas Shaw, Andreas Tinschert, Thomas Zimmermann
  • Publication number: 20020039769
    Abstract: The invention relates to a novel method for the preparation of optically active 3,3,3-trifluoromethyl-2-alkylpropionic acid derivatives of the general formulae (I) and (II), in which R is ethyl or methyl and X is OH or NH2, provided that if R is methyl X≠—OH. The method comprises the reaction of a racemic propionic acid amide of the general formula (III) either by means of microorganisms which are able to use the propionic acid amide in the form of the racemate or one of its optically active isomers as the only nitrogen source or by means of a polypeptide with amidohydrolase activity which is able to hydrolyze the propionic acid amide. The invention also relates to new optically active representatives of this category of compounds.
    Type: Application
    Filed: August 23, 2001
    Publication date: April 4, 2002
    Applicant: LONZA AG
    Inventors: Andrew Naughton, Nicholas Shaw
  • Patent number: 6083712
    Abstract: In DNA fragments and plasmids comprising the bioB, bioF, bioC, bioD and bioA genes responsible for biosynthesis of biotin, or their functionally equivalent genetic variants and mutants from enteric bacteria, the genes are arranged in a transcription unit. These DNA fragments and plasmids can be contained in microorganisms which can be used to produce biotin.
    Type: Grant
    Filed: June 8, 1995
    Date of Patent: July 4, 2000
    Assignee: Lonza A.G.
    Inventors: Olwen Birch, Johann Brass, Martin Fuhrmann, Nicholas Shaw
  • Patent number: 5766893
    Abstract: Microorganisms of interest are capable of utilizing .alpha.-imino carboxamides, in the form of the racemate or of its optically active isomers, of the general formula ##STR1## wherein A together with --NH-- and --CH-- is an optionally substituted 5- or 6-membered saturated heterocyclic ring, as sole nitrogen source, and converting (RS)-.alpha.-imino carboxamides of Formula I into an S-.alpha.-imino carboxylic acid of the general formula ##STR2## These microorganisms are useful also for biconversion of an (RS)-.alpha.-imino carboxamide of Formula I into an S-.alpha.-imino carboxylic acid.
    Type: Grant
    Filed: March 12, 1996
    Date of Patent: June 16, 1998
    Assignee: Lonza AG
    Inventors: Andreas Kiener, Jean-Paul Roduit, Jorg Kohr, Nicholas Shaw
  • Patent number: 5622846
    Abstract: Microorganisms of interest are capable of utilizing .alpha.-imino carboxamides, in the form of the racemate or of its optically active isomers, of the general formula ##STR1## wherein A together with --NH-- and --CH-- is an optionally substituted 5- or 6-membered saturated heterocyclic ring, as sole nitrogen source, and converting (RS)-.alpha.-imino carboximides of Formula I into an S-.alpha.-amino carboxylic acid of the general formula ##STR2## These microorganisms are useful also for biconversion of an (RS)-.alpha.-imino carboxamide of Formula I into an S-.alpha.-amino carboxylic acid.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 22, 1997
    Assignee: Lonza AG
    Inventors: Andreas Kiener, Jean-Paul Roduit, J org Kohr, Nicholas Shaw
  • Patent number: 4309595
    Abstract: A hand held hair dryer housing with a relatively small open end and a relatively large opposite open end, heater means, and a reversible motor-driven fan for selectively providing either a concentrated or a diffused flow of heated air through said small or large open ends of said housing, respectively.
    Type: Grant
    Filed: July 14, 1980
    Date of Patent: January 5, 1982
    Assignee: Sunbeam Corporation
    Inventors: Douglas G. Long, William R. Hemrich, Nicholas A. Shaw